|
BRIP1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.678800E-03 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.922800E-03 |
| Normal-vs-Stage2 |
4.459000E-01 |
| Normal-vs-Stage3 |
4.043200E-03 |
| Normal-vs-Stage4 |
1.162110E-02 |
| Stage1-vs-Stage2 |
1.698480E-03 |
| Stage1-vs-Stage3 |
6.657800E-01 |
| Stage1-vs-Stage4 |
8.800800E-01 |
| Stage2-vs-Stage3 |
4.756800E-03 |
| Stage2-vs-Stage4 |
1.357950E-02 |
| Stage3-vs-Stage4 |
8.419200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.821700E-03 |
| Normal-vs-AfricanAmerican |
3.968100E-02 |
| Normal-vs-Asian |
2.632000E-02 |
| Caucasian-vs-AfricanAmerican |
8.016600E-01 |
| Caucasian-vs-Asian |
2.778800E-01 |
| AfricanAmerican-vs-Asian |
4.773400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.840500E-02 |
| Normal-vs-Female |
5.679700E-03 |
| Male-vs-Female |
3.314600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395190E-03 |
| Normal-vs-Age(41-60Yrs) |
5.369900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.835840E-02 |
| Normal-vs-Age(81-100Yrs) |
1.920790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.839700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.632200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.842000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.616800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.313200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.935200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.785800E-01 |
| Classical-VS-Follicular |
7.75560000000342E-05 |
| Classical-VS-Other |
2.535600E-01 |
| Classical-VS-Normal |
1.775460E-03 |
| Tall-VS-Follicular |
1.302190E-02 |
| Tall-VS-Other |
2.318800E-01 |
| Tall-VS-Normal |
6.258300E-03 |
| Follicular-VS-Other |
8.558200E-01 |
| Follicular-VS-Normal |
4.063800E-01 |
| Other-VS-Normal |
6.311600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.212400E-02 |
| Normal-vs-N1 |
9.796300E-03 |
| N0-vs-N1 |
2.566400E-01 |
|
|
